| Literature DB >> 32649908 |
Cara J Ellison1, Wanda Kukulski2, Keith B Boyle1, Sean Munro2, Felix Randow3.
Abstract
Pathogenic bacteria enter the cytosol of host cells through uptake into bacteria-containing vacuoles (BCVs) and subsequent rupture of the vacuolar membrane [1]. Bacterial invaders are sensed either directly, through cytosolic pattern-recognition receptors specific for bacterial ligands, or indirectly, through danger receptors that bind host molecules displayed in an abnormal context, for example, glycans on damaged BCVs [2-4]. In contrast to damage caused by Listeria monocytogenes, a Gram-positive bacterium, BCV rupture by Gram-negative pathogens such as Shigella flexneri or Salmonella Typhimurium remains incompletely understood [5, 6]. The latter may cause membrane damage directly, when inserting their Type Three Secretion needles into host membranes, or indirectly through translocated bacterial effector proteins [7-9]. Here, we report that sphingomyelin, an abundant lipid of the luminal leaflet of BCV membranes, and normally absent from the cytosol, becomes exposed to the cytosol as an early predictive marker of BCV rupture by Gram-negative bacteria. To monitor subcellular sphingomyelin distribution, we generated a live sphingomyelin reporter from Lysenin, a sphingomyelin-specific toxin from the earthworm Eisenia fetida [10, 11]. Using super resolution live imaging and correlative light and electron microscopy (CLEM), we discovered that BCV rupture proceeds through two distinct successive stages: first, sphingomyelin is gradually translocated into the cytosolic leaflet of the BCV, invariably followed by cytosolic exposure of glycans, which recruit galectin-8, indicating bacterial entry into the cytosol. Exposure of sphingomyelin on BCVs may therefore act as an early danger signal alerting the cell to imminent bacterial invasion.Entities:
Keywords: Gram-negative bacteria; danger receptor; danger signal; membrane damage; sphingomyelin; type 3 secretion system
Mesh:
Substances:
Year: 2020 PMID: 32649908 PMCID: PMC7416114 DOI: 10.1016/j.cub.2020.05.083
Source DB: PubMed Journal: Curr Biol ISSN: 0960-9822 Impact factor: 10.834
Figure 1Lysenin Specifically Binds Sphingomyelin
(A) Constructs of Lysenin used in this study. Green, N-terminal domain; yellow, C-terminal domain.
(B) Liposome flotation assay. Liposomes containing PC:Cholesterol (labeled PC) or Sphingomyelin:PC:Cholesterol (labeled SM) were mixed with recombinant LyseninCTD-GFP purified from E. coli. After incubation, liposomes were floated and harvested. Proteins extracted from supernatant or liposomes were visualized by silver stain. I, input; S, supernatant; B, bound.
(C) Cell-surface binding assay. Non-permeabilized HeLa cells were incubated with recombinant GFP, GFP-Galectin-8, LyseninCTD-GFP, or LyseninCTD,K185A-GFP, washed, and fixed. Binding was assessed by confocal microscopy and flow cytometry. Scale bar, 10 μm. Gray line, unstained; black line, stained with corresponding recombinant protein.
(D) Effect of bSMase on Lysenin binding. Flow cytometry of untreated cells or cells pretreated with recombinant bacterial SMase followed by incubation with recombinant GFP-Galectin-8 or LyseninCTD-GFP.
Figure 2Lysenin Is Recruited to Bacteria-Containing Vacuoles in a Sphingomyelin-Dependent Manner
(A) Confocal micrographs of HeLa cells expressing GFP-LyseninCTD or GFP-LyseninW20A either uninfected or infected with mCherry-expressing S. Typhimurium 12023 and analyzed at 30 min post-infection (p.i.). Two micrographs of the same field of view are presented for HeLa cells expressing GFP-LyseninW20A and infected with S. Typhimurium. The upper image was acquired with identical settings to the uninfected control; the lower image was acquired with a reduced 488 nm laser power. Scale bar, 10 μm.
(B) Percentage of S. Typhimurium positive for LyseninCTD or LyseninW20A at 30 and 60 min p.i. Mean ± SEM of triplicate wells from three independent repeats. Automated image acquisition, automated quantification. n > 6,000 bacteria counted per well.
(C) Confocal micrographs of HeLa cells expressing GFP-LyseninW20A,K185A either uninfected or infected with mCherry-expressing S. Typhimurium and analyzed at 30 min post-infection (p.i.). Scale bar, 10 μm.
(D) Percentage of S. Typhimurium positive for LyseninW20A or LyseninW20A,K185A at 30 and 60 min p.i. Mean ± SEM of triplicate wells from three independent repeats. Automated image acquisition, automated quantification. n > 6,000 bacteria counted per well. ∗∗∗∗p < 0.0001, Student’s t test.
(E) Confocal micrographs of HeLa cells expressing GFP-LyseninW20A and mCherry-galectin-8 following treatment with different sterile damage-inducing reagents. White arrows indicate examples of Lysenin and galectin-8 co-localization. Scale bar, 10 μm
(F) Confocal micrographs of HeLa cells expressing GFP-LyseninW20A and mCherry-nSMase2 infected with S. Typhimurium and analyzed at 60 min p.i. Scale bar, 10 μm.
(G) Percentage of S. Typhimurium positive for LyseninW20A or galectin-8 in the presence or absence of ectopically expressed nSMase2. Mean ± SEM of triplicate wells from three independent repeats. Automated image acquisition, manual quantification. n > 700 bacteria counted per well. Ns, non-significant; ∗∗∗p < 0.001, Student’s t test.
(H) Percentage of S. Typhimurium wild-type (w/type) or ΔprgH + Inv positive for LyseninW20A or galectin-8. Mean ± SEM of triplicate coverslips from three independent repeats. Quantification by eye using wide-field microscopy. n > 200 (w/type), n > 45 (ΔprgH + Inv) bacteria counted per coverslip. ∗∗∗∗p < 0.0001, Student’s t test.
See also Video S1 and Figures S1 and S2.
Figure 3Sphingomyelin Is Exposed on Vacuoles Containing Gram-Negative or Gram-Positive Bacteria and Exposure Occurs before Glycans
(A) Confocal micrographs of HeLa cells expressing LyseninW20A infected with Shigella flexneri M90T, Listeria monocytogenes EGD (BUG 600), Streptococcus pyogenes H293, or Enteropathogenic E. coli E2348/69 (EPEC). Confocal micrograph of THP-1 cells expressing LyseninW20A infected with EPEC. HeLa scale bar, 10 μm; THP-1 scale bar, 5 μm.
(B) Quantification of Lysenin recruitment to S. flexneri and L. monocytogenes. Mean ± SEM of triplicate coverslips from three independent repeats. Quantification by eye using wide-field microscopy. n > 100 bacteria counted per coverslip.
(C) Percentage of S. Typhimurium positive for LyseninW20A and/or galectin-8 at 30 and 60 min p.i. Mean ± SEM of triplicate wells from three independent repeats. Automated image acquisition, manual quantification. n > 700 bacteria counted per well.
(D) Structured illumination micrographs of HeLa cells expressing mCherry-LyseninW20A and YFP-galectin-8 infected with blue fluorescent protein (BFP)-expressing S. Typhimurium and fixed at 60 min p.i.. Scale bar, 1 μm.
(E) Structured illumination micrographs of HeLa cells expressing mCherry-LyseninW20A infected with BFP-expressing S. Typhimurium and stained for galectin-8 and NDP52 at 60 min p.i.. Scale bar, 1 μm.
(F) Quantification of the time interval between Lysenin and galectin-8 recruitment to S. Typhimurium or S. flexneri visualized by live-cell imaging. n > 107 S. Typhimurium and n > 45 S. flexneri events were analyzed. Mean ± SD indicated. ∗∗∗∗p < 0.0001, Student’s t test.
(G) Tracking of a Salmonella-containing vacuole visualized by live-cell imaging. Graph indicates mean 488 nm (green) and 561 nm (red) fluorescence intensity changes around the bottom bacterium in Video S3. Time indicated is from the start of the track rather than bacterial entry into the cell. Graph shown is a representative example.
See also Video S3.
Figure 4Sphingomyelin Is Exposed on the Cytosolic Leaflet of BCVs before Cytosolic Entry of the Bacterium
(A) Selected frames from super resolution live-cell imaging of HeLa cells expressing mCherry-LyseninW20A and YFP-galectin-8 infected with BFP-expressing S. Typhimurium shown in Video S4. White arrow indicates appearance of a break in the SCV membrane. Scale bar, 5 μm.
(B) Selected frames from live-cell imaging of HeLa cells expressing mCherry-LyseninW20A and CFP-galectin-8 infected with GFP-expressing S. flexneri shown in Video S2. Video and corresponding stills were false colored to aid visualization: green, LyseninW20A; red, galectin-8; blue, S. flexneri. White arrow indicates appearance of a break in the SfCV membrane. Scale bar, 2 μm.
(C and D) Correlative fluorescence and electron microscopy of HeLa cells expressing mCherry-LyseninW20A and YFP-galectin-8 infected with BFP-expressing S. Typhimurium 30–40 min post-infection. Left panel: fluorescence images of ∼300 nm sections through resin-embedded cells, merge of red (mCherry signal) and green (YFP signal) channel. White square corresponds to area shown in second panel, imaged by electron tomography. Second panel: virtual slice through electron tomogram, showing SCV identified by fluorescence microscopy. White square corresponds to the area magnified in the third panel. Yellow arrows indicate ruptures of the SCV membrane. Right panel shows 3D segmentation models of the SCV membrane (yellow) and the surface of the bacterium (green). The background is a different virtual slice of the tomogram shown in the second panel. Scale bar, 1 μm (left panel), 100 nm (second and right panel), and 50 nm (third panel).
See also Videos S2, S4, S5, and S6.
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Goat polyclonal anti-galectin 8 | R and D Systems | Cat# AF1305; RRID: |
| Mouse polyclonal anti-NDP52 | Abnova | Cat# H00010241-B01P; RRID: |
| AlexaFluor-conjugated anti-goat or anti-mouse | Invitrogen | Various |
| Gift from David Holden - Imperial College, London | N/A | |
| Gift from David Holden - Imperial College, London | N/A | |
| Gift from Chris Tang – Sir William Dunn School of Pathology, Oxford | N/A | |
| Gift from Pascal Cossart, Institut Pasteur, Paris | N/A | |
| Gift from Imperial College, London | N/A | |
| Enteropathogenic | Gift from David Holden – Imperial College, London | N/A |
| Chemically competent | Lab stock | N/A |
| Chemically competent | Lab stock | N/A |
| Lysenin(CTD)-GFP-His6 | This paper | N/A |
| Lysenin(CTD)-GFP-His6 | This paper | N/A |
| This paper | N/A | |
| Kanamycin | Merck | Cat# 420311 |
| Gentamycin | Thermo Fisher Scientific | Cat #15750045 |
| Isopropyl β-D-1-thioglalctopyranoside (IPTG) | SIGMA | Cat# I5502 |
| Chicken Egg Sphingomyelin | Avanti Polar Lipids Inc. | Cat# 860061 |
| Porcine Brain Phosphatidylcholine | Avanti Polar Lipids Inc. | Cat# 840053 |
| Cholesterol | SIGMA | Cat# C8503 |
| Optiprep | SIGMA | Cat# D1556 |
| Sucrose | SIGMA | Cat# S0389 |
| Polyethylenimine (PEI) | Polysciences | Cat# 23966-2 |
| Complete Protease Inhibitor Cocktail | Roche | Cat #4693116001 |
| Poly(ethyleneglycol) 1000 (PEG) | SIGMA | Cat# 81188 |
| Glycyl-L-phenylalanine 2-naphthylamide (GPN) | SIGMA | Cat# G9512 |
| L-leucyl-L-leucine methyl ester (LLOMe) | Cayman Chemicals | Cat# 16008 |
| Listeriolysin O | Generon Ltd. | Cat# Pro-320 |
| Saponin | Thermo Fisher Scientific | Cat# AC419231000 |
| VECTASHIELD HardSet Antifade Mounting Medium with DAPI | Vector laboratories | Cat# H-1500 |
| DRAQ5 | eBioscience | Cat# 65-0880-92 |
| ProLong gold antifade mountant | Invitrogen | Cat# P36930 |
| Leibovitz’s L-15 medium | GIBCO | Cat# 21083027 |
| Lowicryl HM20 embedding kit | Polysciences, Inc. | Cat# 15924 |
| Silver stain kit | BioRad | Cat# 161-0443 |
| N/A | ||
| HeLa | European Collection of Authenticated Cell Cultures | RRID:CVCL_0030 |
| THP-1 | European Collection of Authenticated Cell Cultures | RRID:CVCL_0006 |
| Murine embryonic fibroblasts | Gift from Chihiro Sasakawa, Univeristy of Tokyo | N/A |
| Primers used in this study are listed in | N/A | |
| Plasmid: pETM-11 His6-GFP | This study | N/A |
| Plasmid: pETM-11 His6-GFP-Galectin 8 | This study | N/A |
| Plasmid: pOPIN K LyseninCTD-GFP-His6 | This study | N/A |
| Plasmid: pOPIN K LyseninCTDK185A -GFP-His6 | This study | N/A |
| Plasmid: pOPIN B | This study | N/A |
| Plasmid: M6P-GFP-LyseninCTD | This study | N/A |
| Plasmid: M6P-GFP-LyseninW20A | This study | N/A |
| Plasmid: M6P-GFP-LyseninW20A K185A | This study | N/A |
| Plasmid: M6P-mCh-LyseninW20A | This study | N/A |
| Plasmid: M6P-mCh-Galectin-8 | Gift from Michal Wandel – MRC LMB, Cambridge | N/A |
| Plasmid: M6P-YFP-Galectin-8 | Wandel M.P et al., 2017 | MW319 |
| Plasmid: M6P-CFP-Galectin-8 | Gift from Michal Wandel – MRC LMB, Cambridge | N/A |
| Plasmid: M6P-mCh-nSMase2 | This study | N/A |
| Synthesized gene: | Life Technologies | N/A |
| Synthesized gene: | Life Technologies | N/A |
| GraphPad Prism | N/A | |
| Zeiss ZEN | N/A | |
| NIS Elements 4.40 | N/A | |
| Imaris version 8 | N/A | |
| FlowJo version 7 | N/A | |
| aCOLyte3 | N/A | |
| Fiji | N/A | |
| SerialEM | N/A | |
| IMOD | N/A | |
| Amira | Thermo Scientific | N/A |
| Hi-Trap Nickel column | GE Healthcare | Cat# 17524801 |
| Superdex 200 16/600 column | GE Healthcare | Cat# 28989335 |
| Superdex 75 16/600 column | GE Healthcare | Cat# 28989333 |
| Resource Q anion exchange column | GE Healthcare | Cat# 17117901 |
| Vivaspin concentrators (10kDa cutoff) | Vivaproducts | Cat# VS2001 |
| Mini-extruder | Avanti Polar Lipids Inc. | Cat# 610023 |
| Nucleopore track etched membranes 400um and 100um | Whatman | Cat# WHA800282; Cat# WHA800309 |
| Sapphire discs, 3mm | Engineering Office M.Wohlwend | Art. 405 |
| Copper gold-plated support ring, 6 mm | Leica Microsystems | Cat# 16770111139 |
| Nickel spacer ring, 3 mm, 2 mm hole | Leica Microsystems | Cat# 16770131268 |
| Cover ring, 6 mm | Leica Microsystems | Cat# 16770111138 |
| Protein A-coated 15 nm gold beads | Electron Microscopy Sciences | Cat# 25287 |
| Copper EM grids with carbon film, 200 mesh | Agar Scientific | Cat# AGS160 |